术前新辅助治疗与根治性放化疗治疗ⅢA(N2)期NSCLC效果的Meta分析(5)
[16] Yang P，Allen MS，Aubry MC，et al. Clinical features of 5 628 primary lung cancer patients：experience at Mayo Clinic from 1997 to 2003 [J]. Chest，2005，128(1)：452-462.[17] Bilfinger T，Keresztes R，Albano D，et al. Five-Year Survival Among Stage ⅢA Lung Cancer Patients Receiving Two Different Treatment Modalities [J]. Med Sci Monit ......
您现在查看是摘要页，全文长 2011 字符。